Watch More Highlights
Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, discusses updates on CAR T-cell therapy and what advanced practitioners need to be aware of when treating patients with rare lymphomas: how best to sequence these agents; the potential acute and long-term toxicities; available clinical trials; and appropriate referral to centers, especially for those who may not have many viable treatment options.